Literature DB >> 24508418

Characterization of type 2 diabetes mellitus burden by age and ethnic groups based on a nationwide survey.

Janice M S Lopez1, Robert A Bailey2, Marcia F T Rupnow2, Kathy Annunziata3.   

Abstract

BACKGROUND: Type 2 diabetes mellitus (T2DM) is the most common form of diabetes. Risk factors for its development include older age, obesity, family history of diabetes, history of gestational diabetes, impaired glucose metabolism, physical inactivity, and race/ethnicity.
OBJECTIVE: The purpose of this study was to characterize T2DM burden, from a patient perspective, with respect to age and race/ethnicity.
METHODS: Adults aged ≥18 years with T2DM from a large, Internet-based, nationwide survey were retrospectively analyzed. Demographic and clinical characteristics (glycemic control, body mass index [BMI], comorbidities, and diabetes-related complications), hypoglycemic episodes, and medication adherence were used to assess diabetes burden. Degree of burden was compared across age (18-64, 65-74, and ≥75 years) and racial/ethnic (white, African American, Hispanic, Asian, and American Indian) groups.
RESULTS: An apparent association was found between glycemic control and medication adherence. Hispanics had the lowest percentage of participants with a hemoglobin A1c (HbA1c) level <7.0% (24.4%) and the highest percentage of those not knowing their HbA1c levels (55.4%) but also had the poorest medication adherence among racial/ethnic groups. Conversely, American Indians and whites had the best glycemic control, HbA1c knowledge, and medication adherence. The 18- to 64-year age group had the poorest glycemic control (28.8%), the most with unknown HbA1c levels (46.3%), and the poorest medication adherence of the age groups. Mean BMIs were high (>30 mg/kg(2)) for all racial/ethnic groups other than the Asian group (28.9 mg/kg(2)). Approximately 71% of Asians were obese or overweight compared with ≥90% in the other racial/ethnic groups. Mean BMIs decreased with increasing age group (34.5, 32.6, and 29.8 kg/m(2) for the age groups of 18-64, 65-74, and ≥75 years, respectively). Regarding diabetes-related comorbidities, the Asian group had the lowest percentages of those with hypertension (39.1%) and hypercholesterolemia (46.6%). The Asian group had the lowest mean Charlson Comorbidity Index (CCI) score (score of 1.4); the American Indian group had the highest CCI score (score of 1.8). Of the age groups, the 65- to 74-year group had the highest percentages of those with hypertension (69.0%) and hypercholesterolemia (67.4%). The mean CCI scores in the 65- to 74-year and ≥75-year age groups (scores of 1.8 for both) were significantly higher than in the 18- to 64-year age group. The Asian group had the lowest percentage of participants reporting hypoglycemia (37.3%). The 18- to 64-year age group had the highest percentage of participants reporting hypoglycemia (52.7%). Limitations of this study include selection bias (Internet-based survey), recall bias, missing values, and descriptive analyses without adjustment for multiplicity.
CONCLUSION: There are many factors that contribute to diabetes burden and the complexity of diabetes management. The results of this study provide insight from a patient perspective regarding how these factors vary across age and race/ethnicity to aid in the individualization of diabetes treatment.
Copyright © 2014 The Authors. Published by EM Inc USA.. All rights reserved.

Entities:  

Keywords:  age; ethnicity; patient perspective; survey; type 2 diabetes

Mesh:

Substances:

Year:  2014        PMID: 24508418     DOI: 10.1016/j.clinthera.2013.12.016

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  21 in total

1.  Racial-ethnic disparities in the association between risk factors and diabetes: The Northern Manhattan Study.

Authors:  Erin R Kulick; Yeseon P Moon; Ken Cheung; Joshua Z Willey; Ralph L Sacco; Mitchell S V Elkind
Journal:  Prev Med       Date:  2015-12-04       Impact factor: 4.018

2.  Efficacy and Safety of Canagliflozin in Type 2 Diabetes Patients of Different Ethnicity.

Authors:  Jaime A Davidson; Richard Aguilar; Fernando J Lavalle González; Angelina Trujillo; Maria Alba; Ujjwala Vijapurkar; Gary Meininger
Journal:  Ethn Dis       Date:  2016-04-21       Impact factor: 1.847

3.  Assessing Barriers to Medication Adherence Among Latinos with Diabetes: a Cross-sectional Study.

Authors:  Andrea Banuelos Mota; Emilio Ernesto Feliz Sala; Jennifer M Perdomo; Joel Alejandro Solis; Walter M Solorzano; Michael Hochman; Jo Marie Reilly
Journal:  J Gen Intern Med       Date:  2019-06-03       Impact factor: 5.128

4.  Attributing discrimination to weight: associations with well-being, self-care, and disease status in patients with type 2 diabetes mellitus.

Authors:  Lindsey Potter; Kenneth Wallston; Paula Trief; Jan Ulbrecht; Vanessa Juth; Joshua Smyth
Journal:  J Behav Med       Date:  2015-07-02

Review 5.  Racial and Ethnic Disparities in Adverse Drug Events: A Systematic Review of the Literature.

Authors:  Avi Baehr; Juliet C Peña; Dale J Hu
Journal:  J Racial Ethn Health Disparities       Date:  2015-03-24

Review 6.  Self-Care Disparities Among Adults with Type 2 Diabetes in the USA.

Authors:  Lindsay Satterwhite Mayberry; Erin M Bergner; Rosette J Chakkalakal; Tom A Elasy; Chandra Y Osborn
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

7.  Gestational hypertension and chronic hypertension on the risk of diabetes among gestational diabetes women.

Authors:  Xiaojing Yuan; Huikun Liu; Leishen Wang; Shuang Zhang; Cuiping Zhang; Junhong Leng; Ling Dong; Li Lv; Fengjun Lv; Huiguang Tian; Lu Qi; Jaakko Tuomilehto; Gang Hu
Journal:  J Diabetes Complications       Date:  2016-05-04       Impact factor: 2.852

8.  RESISTIN INHIBITS GLUCOSE-STIMULATED INSULIN SECRETION THROUGH MIR-494 BY TARGET ON STXBP5.

Authors:  F Wen; Y Yang; C Sun; H Fang; L Nie; L Li; Y Liu; Z Yang
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jan-Mar       Impact factor: 0.877

9.  Adherence to oral antihypertensive medications, are all medications equal?

Authors:  Michal Shani; Alex Lustman; Shlomo Vinker
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-07       Impact factor: 3.738

10.  Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.

Authors:  Josefin Henninger; Ann Hammarstedt; Araz Rawshani; Björn Eliasson
Journal:  BMC Endocr Disord       Date:  2015-09-25       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.